Abstract: The toner contains binder resin-containing toner particles and silica fine particle S1, wherein the weight-average particle diameter of the toner is 4.0-15.0 ?m, both inclusive, peaks originating with the silica fine particle S1 are observed in 29 Si-NMR measurement of the silica fine particle S1, and, in the spectrum obtained by 29Si CP/MAS NMR or 29Si DD/MAS NMR, the peak area of a peak corresponding to the D1 unit structure in the silica fine particle S1, the peak area of a peak corresponding to the D2 unit structure in the silica fine particle S1, and the peak area of a peak corresponding to the Q unit structure in the silica fine particle S1 satisfy a prescribed relationship.

Abstract: A predetermined component such as a recliner is attached to a long member in advance, and thereafter by bending the long member, a pair of side frames and an upper frame are integrally formed. Therefore, the recliner can be attached to the long member not bent yet and thus in a substantially flat state, and in addition, the pair of side frames and the upper frame can be integrally formed, which does not require labor and contributes to a reduction in manufacturing cost. Moreover, by adjusting a position where the bending is performed, it is possible to manufacture seat frame structures different in dimension even if the long members not bent yet have the same length, and from this viewpoint as well, it is possible to reduce labor and manufacturing cost.

Abstract: A predetermined component such as a recliner is attached to a long member in advance, and thereafter by bending the long member, a pair of side frames and an upper frame are integrally formed. Therefore, the recliner can be attached to the long member not bent yet and thus in a substantially flat state, and in addition, the pair of side frames and the upper frame can be integrally formed, which does not require labor and contributes to a reduction in manufacturing cost. Moreover, by adjusting a position where the bending is performed, it is possible to manufacture seat frame structures different in dimension even if the long members not bent yet have the same length, and from this viewpoint as well, it is possible to reduce labor and manufacturing cost.

Abstract: An antiallergic agent for topical administration containing an adenine compound of general formula (1): [wherein ring A represents a 6 to 10 membered, mono or bicyclic, aromatic hydrocarbon or a 5 to 10 membered, mono or bicyclic, aromatic heterocycle containing one to three heteroatoms selected among 0 to 2 nitrogen atoms, 0 or 1 oxygen atom, and 0 or 1 sulfur atom; n is an integer of 0 to 2; m is an integer of 0 to 2; R represents halogeno, (un)substituted alkyl, etc.; X1 represents oxygen, sulfur, NR1 (R1 represents hydrogen or alkyl), or a single bond; Y1 represents a single bond, alkylene, etc.; Y2 represents a single bond, alkylene, etc.; Z represents alkylene; and at least one of Q1 and Q2 represents —COOR10 (wherein R10 represents (un)substituted alkyl, etc.), etc.] or a pharmaceutically acceptable salt of the compound.

Abstract: A drug for topically administration which is effective as an antiallergic agent. The drug for topically administration contains as an active ingredient an adenine compound represented by the general formula (1): [wherein ring A represents a 6 to 10 membered, mono or bicyclic, aromatic hydrocarbon or a 5 to 10 membered, mono or bicyclic, aromatic heterocycle containing one to three heteroatoms selected among 0 to 2 nitrogen atoms, 0 or 1 oxygen atom, and 0 or 1 sulfur atom; n is an integer of 0 to 2; m is an integer of 0 to 2; R represents halogeno, (un)substituted alkyl, etc.; X1 represents oxygen, sulfur, NR1 (R1 represents hydrogen or alkyl), or a single bond; Y1 represents a single bond, alkylene, etc.; Y2 represents a single bond, alkylene, etc.; Z represents alkylene; and at least one of Q1 and Q2 represents —COOR10 (wherein R10 represents (un)substituted alkyl, etc.), etc.] or a pharmaceutically acceptable salt of the compound.

Abstract: An entry information array includes m pieces of entry information corresponding to m directory entries of n directory entries included in a directory entry array. Each of the pieces of entry information includes name information of the directory entry, and allocation position information indicating allocation position of the directory entry in the directory entry array. The entry information search section detects entry information corresponding to a file or a directory, which is a search target, from the entry information array. The directory entry access section refers to the allocation position information included in the detected entry information to detect a directory entry corresponding to the search target from the directory entry array.

Abstract: A vehicle is provided with an identification information memory in which identification information of the vehicle is memorized, and a transmitter for transmitting the identification information. A portable terminal is provided with a receiver for receiving the identification information transmitted from the transmitter, a registration information memory in which identification information of a ridable vehicle is memorized as registration information in advance, and a controller for executing authentication between the identification information and the registration information and executing a warning processing when a result of authentication shows inconsistency.

Abstract: Disclosed is a method for the prevention and/or treatment of a chronic obstructive pulmonary disease by administrating a 5-membered cyclic compound represented by the formula below: or a pharmaceutically acceptable salt of the compound or a prodrug of the compound or salt: wherein X represents an oxygen or sulfur atom; R1 represents a hydrogen atom, a substituted or unsubstituted alkyl or the like; R2 represents a hydrogen atom, a substituted or unsubstituted alkyl or the like; Y1 represents single bond, a substituted or unsubstituted alkylene or the like; the wavy line means an (E) or (Z) coordination; R3 represents a hydrogen atom, a substituted or unsubstituted aryl or the like; Y2 represents a substituted or unsubstituted alkylene or an alkenylene; R4 represents a hydrogen atom, a substituted or unsubstituted alkanoyl or the like; and R5 represents a hydrogen atom or a substituted or unsubstituted alkyl.

Abstract: A drum type washing and drying machine has a water tank (4), a rotary drum rotatably provided in the water tank (5), a dehumidifying heat exchanger for dehumidifying air introduced from inside of the rotary drum (5), a heater unit for heating the air dehumidified by the dehumidifying heat exchanger, and a blower (131) for introducing the air in the rotary drum (5) into the dehumidifying heat exchanger and delivering into the rotary drum (5) the air heated by the heater unit. A filter (160) is placed in a suction-side channel between the rotary drum (5) and the blower and on an upstream side of air flow produced by the blower (131) in a drying process. The filter (160) is placed so as to be soaked in water supplied into the water tank in a washing process or in a rinsing process.

Abstract: Disclosed is a method for the prevention and/or treatment of a chronic obstructive pulmonary disease by administrating a 5-membered cyclic compound represented by the formula below: or a pharmaceutically acceptable salt of the compound or a prodrug of the compound or salt: wherein X represents an oxygen or sulfur atom; R1 represents a hydrogen atom, a substituted or unsubstituted alkyl or the like; R2 represents a hydrogen atom, a substituted or unsubstituted alkyl or the like; Y1 represents single bond, a substituted or unsubstituted alkylene or the like; the wavy line means an (E) or (Z) coordination; R3 represents a hydrogen atom, a substituted or unsubstituted aryl or the like; Y2 represents a substituted or unsubstituted alkylene or an alkenylene; R4 represents a hydrogen atom, a substituted or unsubstituted alkanoyl or the like; and R5 represents a hydrogen atom or a substituted or unsubstituted alkyl.

Abstract: Provided are: a five-membered ring compound represented by formula (1) or a pharmaceutically acceptable salt thereof; and a medicine containing the compound or salt. The compound or salt inhibits the infiltration of leukocytes such as eosinophils and lymphocytes, is effective as a therapeutic agent for various kinds of inflammation, and is so safe that the compound or salt can be taken for long. In formula (1), R1 is (substituted) phenyl or pyridyl; R2 is (substituted) pyrazinediyl, pyrimidinediyl, or pyridazinediyl; R3 to R5 each is alkyl (provided that —N(R4)R5 may be morpholino); and Y2 is alkylene.

Abstract: Disclosed is a five-membered ring compound represented by formula (1) or a pharmaceutically acceptable salt thereof. The compound inhibits infiltration of leukocytes including eosinophils and lymphocytes, and is effective as a drug for treating various inflammations. The compound is highly safe and can be administered for a long period. A pharmaceutical product containing the five-membered ring compound or a pharmaceutically acceptable salt thereof is also disclosed.

Abstract: A drug for topically administration which is effective as an antiallergic agent. The drug for topically administration contains as an active ingredient an adenine compound represented by the general formula (1): [wherein ring A represents a 6 to 10 membered, mono or bicyclic, aromatic hydrocarbon or a 5 to 10 membered, mono or bicyclic, aromatic heterocycle containing one to three heteroatoms selected among 0 to 2 nitrogen atoms, 0 or 1 oxygen atom, and 0 or 1 sulfur atom; n is an integer of 0 to 2; m is an integer of 0 to 2; R represents halogeno, (un)substituted alkyl, etc.; X1 represents oxygen, sulfur, NR1 (R1 represents hydrogen or alkyl), or a single bond; Y1 represents a single bond, alkylene, etc.; Y2 represents a single bond, alkylene, etc.; Z represents alkylene; and at least one of Q1 and Q2 represents —COOR10 (wherein R10 represents (un)substituted alkyl, etc.), etc.] or a pharmaceutically acceptable salt of the compound.

Abstract: A drug for topically administration which is effective as an antiallergic agent. The drug for topically administration contains as an active ingredient an adenine compound represented by the general formula (1): [wherein ring A represents a 6 to 10 membered, mono or bicyclic, aromatic hydrocarbon or a 5 to 10 membered, mono or bicyclic, aromatic heterocycle containing one to three heteroatoms selected among 0 to 2 nitrogen atoms, 0 or 1 oxygen atom, and 0 or 1 sulfur atom; n is an integer of 0 to 2; m is an integer of 0 to 2; R represents halogeno, (un)substituted alkyl, etc.; X1 represents oxygen, sulfur, NR1 (R1 represents hydrogen or alkyl), or a single bond; Y1 represents a single bond, alkylene, etc.; Y2 represents a single bond, alkylene, etc.; Z represents alkylene; and at least one of Q1 and Q2 represents —COOR10 (wherein R10 represents (un)substituted alkyl, etc.), etc.] or a pharmaceutically acceptable salt of the compound.

Abstract: Disclosed is a method for the prevention and/or treatment of a chronic obstructive pulmonary disease by administrating a 5-membered cyclic compound represented by the formula below: or a pharmaceutically acceptable salt of the compound or a prodrug of the compound or salt: wherein X represents an oxygen or sulfur atom; R1 represents a hydrogen atom, a substituted or unsubstituted alkyl or the like; R2 represents a hydrogen atom, a substituted or unsubstituted alkyl or the like; Y1 represents single bond, a substituted or unsubstituted alkylene or the like; the wavy line means an (E) or (Z) coordination; R3 represents a hydrogen atom, a substituted or unsubstituted aryl or the like; Y2 represents a substituted or unsubstituted alkylene or an alkenylene; R4 represents a hydrogen atom, a substituted or unsubstituted alkanoyl or the like; and R5 represents a hydrogen atom or a substituted or unsubstituted alkyl.

Abstract: A play unit plays contents based on a playlist. A storage unit stores playlist schedule information which is indicative of a takeover playlist and a playlist switching condition. A monitoring unit monitors the state of play of contents in the play unit. A switching unit determines whether the play state monitored by the monitoring unit fulfills the playlist switching condition indicated by the playlist schedule information. If the playlist switching condition is determined to be fulfilled, the playlist currently assigned to the play unit is switched to the takeover playlist indicated by the playlist schedule information.

Abstract: A drum type washing and drying machine has a water tank (4), a rotary drum rotatably provided in the water tank (5), a dehumidifying heat exchanger for dehumidifying air introduced from inside of the rotary drum (5), a heater unit for heating the air dehumidified by the dehumidifying heat exchanger, and a blower (131) for introducing the air in the rotary drum (5) into the dehumidifying heat exchanger and delivering into the rotary drum (5) the air heated by the heater unit. A filter (160) is placed in a suction-side channel between the rotary drum (5) and the blower and on an upstream side of air flow produced by the blower (131) in a drying process. The filter (160) is placed so as to be soaked in water supplied into the water tank in a washing process or in a rinsing process.

Abstract: An electronic timepiece with a solar cell includes a timepiece movement, a timepiece case for housing the timepiece movement, a casing ring for housing and holding the timepiece movement in the timepiece case, a solar cell and a dial. The solar cell is disposed almost vertically to a solar cell positioning portion provided in the casing ring, and the solar cell has a slender strip shape formed on a flexible substrate. Consequently, the solar cell is not disposed in the timepiece movement, and it is only necessary to change the casing ring as an external component even when a panel cover diameter is changed. Further, a solar cell can be coiled to match the size of the casing ring when it is incorporated in the casing ring, so that a common solar cell can be used despite a change in the panel cover diameter of the timepiece.

Abstract: A 5-membered cyclic compound of the formula: wherein X is oxygen or sulfur, R1 is hydrogen, substituted or unsubstituted alkyl, etc., R2 is hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted aryl, etc., Y1 is a direct bond, substituted or unsubstituted alkylene, —CO(CH2)n—, etc., the wavy line means (E)-configuration or (Z)-configuration, R3 is substituted or unsubstituted aryl, etc., Y2 is substituted or unsubstituted alkylene, etc., R4 is hydrogen, substituted or unsubstituted alkanoyl, substituted or unsubstituted alkyl, etc., R5 is hydrogen, etc., or a salt thereof, these compound being able to inhibit infiltration of leukocytes such as eosinophils and lymphocytes, by which being useful for the treatment of various kinds of inflammation.